The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
| Sherif M Badawy, MD, MS | |
| (312) 227-4836 | |
| [email protected] |
| Savannah Winkler, BS | |
| (312) 227-4807 | |
| [email protected] |
12 Years - 21 Years
Not Applicable
Interventional
All
Behavioral
Age 12-21 years old
Any sickle cell disease genotype
On steady state of hydroxyurea for 2 months
Own of have access to a smartphone during the study period
Recent hospitalizations within the past 7 days